Effectus
1.Antioxidant possessiones, corrumpere potest liberas radicales et cellulas ab damno oxidative custodire.
2. Anti-inflammatio effectus;potest minuere inflammationem corporis et levandi molestiam.
3.Potential anticancer effectus, incrementum et multiplicationem cellularum cancri inhibere potest.
4. Regulare sanguinem pressuram et sanitatem cardiovascularem emendare.
5. Promovenda cutis sanitatis et senescit minuendi signa.
Testimonium Analysis
Product Name | Apigenin Pulvis | OPIFICIUM Date | 2024.6.10 | |
quantitas | 500KG | Analysis Date | 2024.6.17 | |
Batch No. | BF-240610 | Exitus Date | 2026.6.9 | |
Items | Specifications | Proventus | Methodus | |
Pars Plantae | totum herba | Comforms | / | |
Patria Origin | China | Comforms | / | |
Assay | 98% | 98.2% | / | |
Aspectus | Lux YellowPulvis | Comforms | GJ-QCS-108 | |
Odor&Sapor | Proprium | Comforms | GB/T 5492-2008 | |
Magnitudo particula | >95.0%per80 mesh | Comforms | GB/T 5507-2008 | |
Damnum in Siccatio | ≤.5.0% | 2.72% | GB/T 14769-1993 | |
Cinis Content | ≤.2.0% | 0.07% | AOAC 942.05,18th | |
Totalis Metal | ≤10.0ppm | Comforms | USP <231>, methodus | |
Pb | <2.0ppm | Comforms | AOAC 986.15,18th | |
As | <1.0ppm | Comforms | AOAC 986.15,18th | |
Hg | <0.5ppm | Comforms | AOAC 971.21,18th | |
Cd | <1.0ppm | Comforms | / | |
Microbiological Test |
| |||
Totalis comitis Plate | <1000cfu/g* | Comformae | AOAC990.12,18th | |
Fermentum & Mold | <100cfu/g | Comformae | FDA (BAM) Chapter 18,8th Ed. | |
E.Coli | Negative | Negative | AOAC997,11,18th | |
Salmonella | Negative | Negative | FDA(BAM) Chapter 5,8th Ed | |
Packaetas | In sacculo plastico intus et aluminium claua folliculi foris referta. | |||
Repono | Condite in loco frigido et sicco, abstinete a luce et calore forti. | |||
Vita fasciae | biennio rite conditum. | |||
conclusio | Sample secundum quid. |